Back to Search
Start Over
Urine DNA for monitoring chemoradiotherapy response in muscle-invasive bladder cancer: a pilot study.
- Source :
-
BJU international [BJU Int] 2022 Jan; Vol. 129 (1), pp. 32-34. Date of Electronic Publication: 2021 Sep 20. - Publication Year :
- 2022
- Subjects :
- Antineoplastic Combined Chemotherapy Protocols therapeutic use
Biomarkers, Tumor urine
Cetuximab administration & dosage
Chemoradiotherapy
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
DNA, Neoplasm analysis
Fluorouracil administration & dosage
Humans
Liquid Biopsy
Mitomycin administration & dosage
Muscle, Smooth pathology
Mutation
Neoplasm Invasiveness
Neoplasm Recurrence, Local genetics
Pilot Projects
Receptor, Fibroblast Growth Factor, Type 3 genetics
Sequence Analysis, DNA
Telomerase genetics
Treatment Outcome
Tumor Suppressor Protein p53 genetics
Urinary Bladder Neoplasms genetics
Urinary Bladder Neoplasms pathology
DNA, Neoplasm urine
Neoplasm Recurrence, Local urine
Urinary Bladder Neoplasms therapy
Urinary Bladder Neoplasms urine
Subjects
Details
- Language :
- English
- ISSN :
- 1464-410X
- Volume :
- 129
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BJU international
- Publication Type :
- Academic Journal
- Accession number :
- 34491610
- Full Text :
- https://doi.org/10.1111/bju.15589